Results 31 to 40 of about 4,800,081 (359)

Cerebral Vascular Toxicity of Antiretroviral Therapy

Journal of Neuroimmune Pharmacology, 2019
HIV infection is associated with comorbidities that are likely to be driven not only by HIV itself, but also by the toxicity of long-term use of antiretroviral therapy (ART). Indeed, increasing evidence demonstrates that the antiretroviral drugs used for
L. Bertrand, Martina Velichkovska, M. Toborek   +2 more
semanticscholar   +1 more source

A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: the UK-Vanguard Study [PDF]

, 2006
Objective: The objective of the trial was to evaluate in a pilot setting the safety and efficacy of interleukin-2 (IL-2) therapy when used without concomitant antiretroviral therapy as a treatment for HIV infection.
Abrams, Ann Sullivan, Carr, Carr, Carr, Christian Herzmann, Clive Loveday, Connelly, Crespo-Fierro, Davey, Davey, Davey, Dewar, Emery, Emery, Emery, George Janossy, H. Clifford Lane, Handan Wand, Jorge A Tavel, Kovacs, Kovacs, Lederman, Levy, Lisa Fosdick, Losso, Margaret A Johnson, Mark Nelson, Martin Fisher, Matthews, Mercolino, Mike Youle, Palella, Pillay, Pozniak, Richard T Davey, Ruxrungtham, Sean Emery, Sereti, Sereti, Smith, Stein, Urdea, Verbeke, Yeni   +44 more
core   +2 more sources

Survival rate of HIV-infected children after initiation of the antiretroviral therapy and its predictors in Ethiopia: A facility-based retrospective cohort

SAGE Open Medicine, 2019
Objective: To determine the survival rate and predictors of HIV-infected children on antiretroviral therapy at two selected facilities in North Ethiopia.
Getachew Arage, Mekonnen Assefa, Teshager Worku, Agumasie Semahegn   +3 more
doaj   +1 more source

Factors of Loss to Follow-up Antiretroviral Therapy in Islanded Area

Unnes Journal of Public Health, 2018
Loss to follow-up of antiretroviral therapy is when PLWHA (People Living with HIV/AIDS) do not come for antiretroviral therapy for more than 3 months. This study aimed to determine the factors of loss to follow-up antiretroviral therapy for PLWHA at Prof.
Thomas Laga Boro, Rafael Paun, Marthen R Pellokila   +2 more
doaj   +1 more source

Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi. [PDF]

PLoS ONE, 2013
Smear-positive pulmonary TB is the most infectious form of TB. Previous studies on the effect of HIV and antiretroviral therapy on TB treatment outcomes among these highly infectious patients demonstrated conflicting results, reducing understanding of ...
Hannock Tweya, Caryl Feldacker, Sam Phiri, Anne Ben-Smith, Lukas Fenner, Andreas Jahn, Mike Kalulu, Ralf Weigel, Chancy Kamba, Rabecca Banda, Matthias Egger, Olivia Keiser   +11 more
doaj   +1 more source

Antiretroviral drug resistance mutations in naïve and experienced patients in Shiraz, Iran, 2014 [PDF]

, 2016
Resistance to antiretroviral agents is a significant concern in the clinical management of HIV-infected individuals, particularly in areas of the world where treatment options are limited.
Aghasadeghi, M.R., Baesi, K., Davarpanah, M.A., McFarland, W., Moradi, A., Naziri, H., Tabarraei, A.   +6 more
core   +1 more source

Magnitude of antiretroviral treatment failure and associated factors among adult HIV-positive patients in Harar public hospitals, Eastern Ethiopia

SAGE Open Medicine, 2020
Background: Antiretroviral treatment failure occurred when the antiretroviral regimen is unable to control HIV infection. There is no information on antiretroviral therapy failure in this study area.
Rahel Feleke, Biftu Geda, Kedir Teji Roba, Fitsum Weldegebreal   +3 more
doaj   +1 more source

Medication adherence to antiretroviral therapy among newly treated people living with HIV

BMC Public Health, 2018
BackgroundFree antiretroviral therapy has been implemented in China since 2004, but adherence to antiretroviral therapy among people living with HIV is suboptimal.
Yang Yu, D. Luo, Xi Chen, Zhulin Huang, Min Wang, Shuiyuan Xiao   +5 more
semanticscholar   +1 more source

Effect of point-of-care early infant diagnosis on antiretroviral therapy initiation and retention of patients

AIDS (London), 2018
Objective: We measured the effect of point-of-care (POC) early infant HIV testing on antiretroviral therapy initiation rates and retention in care among infants in Mozambique.
I. Jani, B. Meggi, Osvaldo Loquiha, O. Tobaiwa, Chishamiso Mudenyanga, Alcina Zitha, Dadirayi Mutsaka, N. Mabunda, A. Vubil, T. Bollinger, L. Vojnov, T. Peter   +11 more
semanticscholar   +1 more source

Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016. [PDF]

PLoS ONE, 2018
INTRODUCTION:Antiretroviral therapy reduces the risk of serious illness among people living with HIV and can prevent HIV transmission. We implemented a Test, Treat, and Prevent HIV Program among men who have sex with men (MSM) and transgender women at ...
Sumet Ongwandee, Cheewanan Lertpiriyasuwat, Thana Khawcharoenporn, Ploenchan Chetchotisak, Ekkachai Thiansukhon, Niramon Leerattanapetch, Banlang Leungwaranan, Chomnad Manopaiboon, Thanongsri Phoorisri, Prin Visavakum, Bongkoch Jetsawang, Monsicha Poolsawat, Somboon Nookhai, Monthinee Vasanti-Uppapokakorn, Samart Karuchit, Chonticha Kittinunvorakoon, Philip Mock, Dimitri Prybylski, Ake-Chittra Sukkul, Thierry Roels, Michael Martin   +20 more
doaj   +1 more source